MoneyWorks4Me

The sales surged to Rs. 5610.00 millions, up 35.84% for the June 2026 quarter as against Rs. 4130.00 millions during the corresponding quarter previous year.Handsome Net Profit growth of 55.07% reported above the corresponding previous quarter figure of Rs. 1070.00 millions to Rs. 690.00 millions.Operating Profit saw a handsome growth to 1910.00 millions from 1560.00 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 5610.00 4130.00 35.84 5610.00 4130.00 35.84 17390.00 14020.00 24.04
Other Income 330.00 250.00 32.00 330.00 250.00 32.00 1370.00 550.00 149.09
PBIDT 1910.00 1560.00 22.44 1910.00 1560.00 22.44 6540.00 3550.00 84.23
Interest 430.00 410.00 4.88 430.00 410.00 4.88 1760.00 1990.00 -11.56
PBDT 1480.00 1150.00 28.70 1480.00 1150.00 28.70 5030.00 1560.00 222.44
Depreciation 410.00 460.00 -10.87 410.00 460.00 -10.87 1860.00 1680.00 10.71
PBT 1070.00 690.00 55.07 1070.00 690.00 55.07 3170.00 -120.00 -2741.67
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1070.00 690.00 55.07 1070.00 690.00 55.07 3170.00 -120.00 -2741.67
Equity 810.00 810.00 0.00 810.00 810.00 0.00 810.00 810.00 0.00
PBIDTM(%) 34.05 37.77 -9.86 34.05 37.77 -9.86 37.61 25.32 48.52

Wockhardt Share Price

1885.80 55.65 (3.04%)
21-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.90
Dr. Reddys Labs. 1175.00
Cipla 1426.20
Lupin 2193.00
Zydus Lifesciences 1120.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: